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Chronic infections with persistent pathogens such as helminths, mycobacteria, Plasmodium, and hepatitis
viruses affect more than a third of the human population and are associated with increased susceptibility
to other pathogens as well as reduced vaccine efficacy. Although these observations suggest an impact
of chronic infections in modulating immunity to unrelated antigens, little is known regarding the underlying
mechanisms. Here, we summarize evidence of the most prevalent infections affecting immunity to unrelated
pathogens and vaccines, and discuss potential mechanisms of how different bystander chronic infections
might impact immune responses. We suggest that bystander chronic infections affect different stages of
host responses andmay impact transmission and recognition of other pathogens, innate immune responses,
priming and differentiation of adaptive effector responses, as well as the development and maintenance of
immunological memory. Further understanding of the immunological effects of coinfection should provide
opportunities to enhance vaccine efficacy and control of infectious diseases.Introduction
Diseases from persistent infections impact a large portion of
humanity. Chronic infections with intestinal helminths,Mycobac-
terium, Plasmodium, and hepatitis viruses affect more than
a third of the global population. In developing countries, in
particular, infection with at least one persistent pathogen is
common. Although major efforts are focused on the control of
persistent pathogens, current vaccines and treatments for
many of these infections are lacking, ineffective, or unavailable.
In addition to diseases directly caused by these pathogens,
mounting evidence suggests that persistent infections can alter
immunity to unrelated pathogens and vaccines. In some cases,
coinfections may provide a benefit to the host (Barton et al.,
2007; Xiang et al., 2001). However, much of the existing epidemi-
ological evidence suggests a negative impact of chronic coin-
fections on host immune responses. The high incidence of
coinfection with multiple chronic pathogens suggests an in-
creased susceptibility to secondary infections. Moreover,
responses to many vaccines are reduced in chronically infected
patients, rendering those individuals (often young children) more
susceptible to subsequent infections. Although numerous
observational studies have associated bystander chronic infec-
tions with altered immune responses to unrelated pathogens
or vaccines, the immunological mechanisms underlying these
effects remain poorly understood.
In this review, we discuss the effects of bystander chronic
infections on immune responses to secondary pathogens and
vaccines based largely on epidemiological and clinical observa-
tions. Many variables, such as nutritional or socioeconomical
status, age, and gender may affect the outcome of chronic infec-
tions or efficiency of vaccines, but here we focus on the potential
immunological pathways that might be altered by bystander
chronic infections. The dramatically reduced vaccine efficacy
that has been noted in developing versus industrialized countries
(Cherian et al., 2012) suggests that a more systematic under-458 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.standing of the effects of bystander chronic infections could
improve vaccines and treatments for infectious diseases world-
wide.
High Incidence of Coinfection Suggests that Chronic
Infections Increase Susceptibility to Unrelated
Infections
Epidemiological studies suggest that chronic infections can
predispose patients to secondary infections. Since many patho-
gens causing chronic pathology are coendemic, one could argue
that the high rate of coinfection is simply due to enhanced coex-
posure. Although the geographical overlap of pathogen spread
cannot be excluded as a potentially contributing factor, mathe-
matical models suggest that chronic infections, such as malaria
and human immunodeficiency virus (HIV), actively contribute to
the increased rate of infection with unrelated pathogens (Abu-
Raddad et al., 2006). In the following sections, we discuss
evidence that representative chronic parasitic, bacterial, or viral
infections with high global prevalence impact immunity to
secondary pathogens or vaccines. The majority of epidemiolog-
ical data support a negative effect of chronic bystander infec-
tions in regulating immunity to subsequent unrelated infections.
However, studies suggesting that other chronic infections
provide some immunological benefits to the host will be also dis-
cussed in a later section. The pathogens discussed here are not
intended to be an inclusive set, and many other data sets exist
from epidemiological and/or animal model studies, some of
which are summarized in Table 1. The examples below are
chosen, rather, to illustrate key points that may give insights to
common underlying immunological mechanisms.
Although considerable epidemiological data suggest that
chronic bystander infections affect susceptibility to unrelated
pathogens, it is challenging to compare studies that examine
different ethnic backgrounds, age groups, and/or different
stages of the chronic infection. Thus, data from small-scale
Table 1. Representative Examples of Chronic Bystander Infections Affecting Susceptibility to and/or Outcome of Unrelated
Infections
Bystander Chronic Infection Unrelated Infection Affected Outcome of Coinfection Representative References
Helminths Plasmodium Exacerbation of malaria during
acute phase; reduced severity
during chronic phase
Nacher et al., 2002; Le Hesran et al.,
2004; Sokhna et al., 2004; Briand
et al., 2005
Mycobacterium Increased pathology Resende Co et al., 2007
HCV Increased risk of developing chronic
disease; advanced liver disease
Kamal et al., 2001
HIV Increased susceptibility to HIV;
controversial results on viral loads
Gopinath et al., 2000; Wolday et al.,
2002; Modjarrad et al., 2005; Brown
et al., 2005
Plasmodium Mycobacterium Exacerbation of disease, reactivation
of latent infection
Hawkes et al., 2010
EBV Reactivation of EBV Donati et al., 2006
HIV Increased viremia Pisell et al., 2002; Kublin et al., 2005
Mycobacterium Plasmodium Amount of IFN produced determines
susceptibility to malaria in resistant/
susceptible murine strains
Page et al., 2005; Leisewitz et al., 2008
HIV Enhanced AIDS disease and
mortality
Whalen et al., 1995
Viral Hepatitis Plasmodium Reduced and slower progression
to parasitemia
Ouwe-Missi-Oukem-Boyer et al., 2011;
Andrade et al., 2011
Schistosoma Increased pathology and mortality Zaki et al., 2003
HIV Advanced AIDS disease and
mortality
d’Arminio Monforte et al., 2009; Chun
et al., 2012
HSV HIV Increased HIV replication and
transmission
Schacker et al., 2002; Freeman
et al., 2006
Helicobacter Mycobacterium Reduced risk of progression to
active disease
Perry et al., 2010
Toxoplasma Increased parasite replication and
disease severity
Stoicov et al., 2004
Leishmania HIV Increased viral replication Cacopardo et al., 1996
Studies mentioned here represent only a portion of available epidemiological data existing to illustrate underlying mechanisms of interactions.
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However, when viewed together, some general themes emerge
that should allow hypothesis generation for future larger and/or
mechanistic studies.
HIV infection represents a special case for the discussion of
bystander chronic infections, given that HIV infects and kills
CD4 T cells, resulting in overt immunosuppression. In some
cases, poor immune responses to other antigens during HIV
coinfection do not correlate with CD4 T cell deficiency or HIV viral
loads (Brydak et al., 1999; Bickel et al., 2011), suggesting that
mechanisms besides overt immunodeficiency may exist.
However, the role of chronic HIV as a bystander infection
affecting responses to unrelated pathogens will not be explored
in detail here. Instead, further discussion of coinfections
involving HIV will focus on HIV not as the ‘‘bystander’’ but as
the ‘‘unrelated’’ or ‘‘secondary’’ infection, and how other chronic
infections may impact responses to HIV.
Helminths and Coinfections: A Role for Cytokine
Skewing?
Persistent infections with parasitic helminths affect more than
a billion people, and coinfections with helminths and unrelated
parasitic, bacterial, or viral pathogens are very common, partic-ularly in developing countries. Nevertheless, the interaction
between helminths and Plasmodium, the causative agent of ma-
laria, is controversial. Some studies suggest that chronic
helminth infections protect from cerebral malaria and reduce
parasite burden (Nacher et al., 2002; Briand et al., 2005). In
contrast, other studies have shown an increased risk of devel-
oping malaria and increased severity of malaria symptoms due
to bystander helminth infections (Le Hesran et al., 2004; Sokhna
et al., 2004). These broadly discussed discrepancies could, in
part, be attributed to the fact that the acute phase of infection
with the trematode Schistosoma promotes a Th1 type of inflam-
mation, which is predominantly associated with cell-mediated
immunity and resistance to intracellular pathogens and could
potentially increase Plasmodium-induced pathology. By con-
trast, the chronic phase of helminth infections is associated
with a Th2/regulatory cytokine milieu, which can attenuate Th1
responses that are immunopathogenic for malaria (Hartgers
and Yazdanbakhsh, 2006). These discordant epidemiological
findings illustrate the immunological complexities of chronic co-
infection, where the timing of acquisition of the second pathogen
might be critical in the context of a dynamic immunological envi-
ronment due to a pre-existing bystander infection.Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 459
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such as hepatitis C virus (HCV) or HIV. Coinfection with Schisto-
soma increases the risk of proceeding from acute to chronic HCV
infection and enhances viral burden and disease progression
(Kamal et al., 2001). Similarly, helminths may promote suscepti-
bility to HIV (Gopinath et al., 2000). However, the benefit of anti-
helminthic treatment during HIV infection has been the subject of
considerable debate. In some studies, deworming was benefi-
cial for reducing HIV viral load (Wolday et al., 2002); in others it
was not (Modjarrad et al., 2005; Brown et al., 2005). A more
systematic review of the literature, however, supported a benefi-
cial effect of antihelminthic treatment for reducing HIV viral loads
(Walson and John-Stewart, 2007). The inability to estimate the
exact timing of acquisition of either infection, as well as the small
sample sizes in many of these studies, may account for these
discrepancies and have limited broad conclusions on this issue,
emphasizing the need for further investigation.
Tuberculosis Infection Can Impact the Outcome of
Unrelated Viral or Parasitic Infections
Coinfection with the intracellular bacterium Mycobacterium
tuberculosis (Mtb) and HIV is one of themost prevalent and lethal
combinations of coinfection. Development of active tuberculosis
caused by Mtb accelerates the clinical course of HIV infection
and is associated with increased mortality in HIV patients
(Whalen et al., 1995). Mathematical models have predicted that
treatment of latent and active tuberculosis delays the onset of
AIDS (Bhunu et al., 2009), suggesting that the detrimental effects
of this coinfection are not simply due to HIV-mediated immuno-
suppression but rather due to a reciprocal pathogen interaction.
Animal studies support this hypothesis, as upon Mtb infection,
macaques infected with simian immunodeficiency virus (SIV),
a close relative of HIV, show increased viral load, enhanced
CD4 T cell decline, and increased mortality (Zhou et al., 1999).
Together, these data provide a strong rationale for the appreci-
ated importance of early detection and management of tubercu-
losis in HIV-coinfected patients, but also suggest a complex set
of immunological interactions during HIV/Mtb coinfections.
Mtb infections can also impact subsequent parasitic infec-
tions, such as malaria. Interferon (IFN) responses are crucial
for sustaining immune control of chronic Mtb infection and
may represent a predictive biomarker of Mtb disease (Berry
et al., 2010). A fine balance in the amount of IFN-g produced
upon Mtb infection may determine the outcome of Plasmo-
dium/Mtb coinfection: optimal amounts of IFN-g may protect
from subsequent Plasmodium infection, while uncontrolled
IFN-g production may result in enhanced susceptibility to ma-
laria and/or pathogenesis (Page et al., 2005; Leisewitz et al.,
2008). The potential contribution of additional mechanisms,
such as intrinsic defects in lymphocyte subsets or proliferative
defects caused by chronic Mtb infection, remains to be exam-
ined in these settings.
Malaria Affects Pathology Induced by Bacterial or Viral
Infections
While mycobacterial infections can impact responses tomalaria,
the reverse interaction between Plasmodium and Mtb has also
been observed, predominantly in animal models. In a mouse
model of coinfection, Plasmodium infection exacerbated acute
mycobacterial infection, increased bacterial growth by almost
60%, and induced reactivation of latent Mtb (Hawkes et al.,460 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.2010). Given the significant geographic overlap of these two
infections, unraveling the mechanisms of how malaria might
modify Mtb infection and vice versa could be of considerable
clinical importance.
Plasmodium infection also impairs responses to viral patho-
gens, such as HIV. Mathematical models have suggested
a mutual interaction between these two infections responsible
for the spread of both pathogens in coendemic areas (Abu-
Raddad et al., 2006). Patients with malaria present with higher
HIV viral burden, an effect that could be abrogated upon parasite
clearance (Pisell et al., 2002; Kublin et al., 2005). Since the timing
of acquisition of HIV infection in relation to Plasmodium infection
is usually unknown, animal models may provide a more con-
trolled and mechanistic dissection of the immunological interac-
tions between Plasmodium and HIV. Indeed, studies in rhesus
macaques indicated that established malaria infection acceler-
ates CD4 T cell decline upon subsequent SIV infection and
enhances SIV disease progression (Koehler et al., 2009). There-
fore, the high incidence of malaria/HIV coinfection cannot
be completely attributed to HIV-induced immunodeficiencies.
Rather, a bidirectional interaction between these two pathogens
likely exists.
Chronic Viral Infections Affect Immune Responses
to Other Pathogens
The high incidence of HIV/hepatitis B virus (HBV) or HIV/HCV
coinfection has been attributed to the similar modes of transmis-
sion, as well as HIV-induced immunosuppression. However, the
impact of hepatitis viral infections on the course of HIV infection
remains controversial. Some studies have not detected an effect
of HBV or HCV on the progression of HIV infection, but others
have defined an up to 2.6-fold increase in the risk of developing
AIDS-related illness due to HCV coinfection (Piroth, 2009;
d’Arminio Monforte et al., 2009). These different observations
might relate, at least in part, to different stages of HIV disease
progression. Indeed, a recent study in a large cohort with known
duration of HIV infection detected a 2-fold increase in the risk for
progression to AIDS or death in HIV/HBV coinfected patients
(Chun et al., 2012). Further, clinical evidence suggests that
chronic hepatitis viral infections affect pathology and morbidity
induced by Schistosoma infection (Zaki et al., 2003). Besides
chronic hepatitis viruses, other persistent viral pathogens, such
as herpes simplex virus type 2 (HSV-2), have a well-recognized
role in affecting immunity to unrelated pathogens, such as HIV.
HSV-2 infection has been associated with an 3-fold increased
risk in HIV acquisition, and reactivation of HSV-2 from latency
increased HIV viral replication (Schacker et al., 2002; Freeman
et al., 2006). These studies suggest that a critical factor in pre-
venting or treating global health threats such as HIV, and even
vaccine-preventable diseases such as polio and rotavirus, may
be addressing the effects of coinfections.
Chronic Infections Impair Development of Protective
Immunity following Vaccination
The examples discussed above have focused on clinical and
experimental observations from different types of chronic para-
sitic, bacterial, and viral infections affecting the largest numbers
of people globally. While these studies shed light on the effects
of chronic coinfection, our understanding of the precise immu-
nological pathways associated with altered immunity remains
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data sets on coinfection. First, in settings where two different
pathogens infect the same host, it is often difficult to define
how the replication and/or pathogenesis of each infection might
be altered. Subsequently, changes in pathogenesis can have
a profound impact on the developing immune responses.
Second, especially when examining coinfections in the devel-
oping world, the timing of acquisition of each infection is usually
unknown, and ascribing ‘‘bystander’’ and ‘‘secondary infection’’
status to the different pathogens is often somewhat arbitrary.
Studies on vaccination, on the other hand, allow a more
controlled evaluation of the effects of chronic infections as
‘‘bystanders’’ to the vaccine.
The geographic overlap between poor immune responses to
vaccination and persistent infections such as those discussed
above suggests that, in addition to impacting other infec-
tions, bystander chronic infections may also negatively affect
responses to vaccination. Several other factors, such as malnu-
trition, poor health practices, and nonadherence to vaccination
protocols, should not be overlooked in these settings, but there
is accumulating evidence that chronic infections actively impact
efficacy of vaccines. These data on vaccination suggest that
additional studies on coinfection are warranted, since the target
population for vaccines against some of the most challenging
global infectious diseases, such as HIV, malaria, and tubercu-
losis, is often chronically infected with other pathogens. In addi-
tion to the urgent need to understand how to enhance vaccine
efficacy in the developing world, studies on vaccination in the
context of chronic infections also provide insights into potential
underlying immunological effects of bystander chronic infec-
tions. In these settings, the timing of initiating the vaccine-
targeted response is known, and often the ‘‘optimal’’ response
to the vaccine in noninfected cohorts has been defined.
Vaccination during Helminth Infections
Helminth infections have been associated with lower re-
sponses to vaccinations for tetanus toxoid (Sabin et al., 1996;
Nookala et al., 2004), cholera (Cooper et al., 2001), and Bacille
Calmette-Guerin (BCG), the vaccine for tuberculosis (Elias
et al., 2001). Upon vaccination of helminth-infected individuals,
reduced T cell proliferation and Th1 cytokine production, in-
creased production of the cytokine interleukin (IL)-10, and lower
levels of antibody isotypes IgG2, IgG3, and IgG4 were detected,
effects that were in some cases overcome by antihelminthic
treatment (Elias et al., 2001; Cooper et al., 2001; Nookala
et al., 2004). Thus, the effects of helminth infection on vaccine-
induced responses are consistent with observations from
chronic helminth coinfections and suggest a major contribution
of Th2 skewing but also possible effects on lymphocyte effector
function.
Vaccination during Malaria
Children with malaria develop weaker antibody responses to
Salmonella typhi, tetanus toxoid, meningococcal polysaccha-
ride, and Haemophilus influenzae vaccination (Cunnington and
Riley, 2010). Antimalaria treatment may enhance responses to
meningococcal polysaccharide and tetanus toxoid vaccination,
but not to measles vaccination (Rosen and Breman, 2004;
Cunnington and Riley, 2010), suggesting that responses to
different vaccine antigens may be differentially affected by
a bystander Plasmodium infection. In a recent primate study,malaria was shown to reduce the efficacy of a DNA-based SIV
vaccine by decreasing vaccine-induced CD4 and CD8 T cell
responses (Yin et al., 2012). Thus, the clinical data indicate
substantial defects in vaccine-induced antibody responses in
malaria-infected individuals, while animal models also support
the notion of T cell defects. Unlike chronic helminths, Plasmo-
dium parasites promote Th1 responses. Therefore the mecha-
nism(s) of how different bystander infections may impact new
immune responses could extend beyond the disruption of Th1/
Th2 cytokine equilibrium.
Vaccination during Chronic HCV Infection
Chronic HCV infection moderately affects responses to hepatitis
A virus (HAV) or influenza virus vaccination (Majda-Stanislawska
et al., 2004; Gaeta et al., 2002). More prominent is the effect of
chronic HCV on HBV vaccination, with HBV seroconversion as
low as 50% reported in HCV-infected subjects, independently
of serum HCV titers (Wiedmann et al., 2000; Elefsiniotis et al.,
2006; Moorman et al., 2011). Some data indicate that, despite
later defects, early responses (i.e., 1month) following HBV vacci-
nation were normal (Lee et al., 1999), suggesting that the main
defect caused by chronic HCV may be in the long-term mainte-
nance of protective immunity. While most of these studies have
examined only protective antibody production, they suggest that
T cell responses (i.e., to help T-dependent antibody responses
and perhaps development of immunological memory) may also
be affected.
How Do Bystander Chronic Infections Affect Immune
Responses to Unrelated Antigens?
The observations discussed above largely support the notion
that chronic bystander infections affect immune responses to
unrelated antigens, secondary infections, and vaccines. Indeed,
conventional clinical practice is often to avoid vaccinating
patients with fevers or infections. However, in the developing
world, where chronic infections causing pathology and immuno-
logical alterations are the norm, vaccinating only individuals
lacking bystander infections is likely impractical or impossible.
Thus, a better understanding of how bystander chronic infec-
tions influence immunity to new antigens is needed. Several
mechanisms may be responsible for the increased susceptibility
to unrelated infections in chronically infected patients. Different
stages of host-pathogen interaction and developing immune
responses could be impacted by bystander chronic infections,
including (a) initial pathogen entry or vaccine uptake and innate
immune responses, (b) altered antigen-presenting cell (APC)
function and initial priming of B and T lymphocytes, (c) develop-
ment of host effector mechanisms and lymphocyte differentia-
tion, and (d) development and/or maintenance of immunological
memory (Figure 1). Each of these is discussed in more detail
below.
Bystander Chronic Infections, Initial Pathogen Entry, or
Vaccine Uptake and Innate Immune Responses
Many pathogens need to efficiently penetrate host epithelial
barriers, and some important vaccines can be administered via
mucosal routes. Several chronic infections discussed above
could affect pathogen (and possibly vaccine) entry through
mucosal barriers (Figure 1). For example, helminth infections
affect the integrity of epithelial layers by disrupting epithelial tight
junctions and increasing epithelial permeability (Su et al., 2011),Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 461
Figure 1. Potential Mechanisms by which Bystander Chronic Infections May Affect Immune Responses to Unrelated Antigens
Bystander chronic infections, such as helminths, malaria, tuberculosis, and viral hepatitis, may affect different stages of a developing immune response to
unrelated pathogens or vaccines.
(A) Pathogen entry though mucosal/epithelial barriers or vaccine uptake is illustrated as an event that may be altered by bystander chronic pathogens.
Dysregulation of innate immune responses and reduced production of early antimicrobial mediators could impact initial pathogen replication.
(B) Reduced or altered APC function including antigen processing and presentation, costimulation, and cytokine production may alter initial lymphocyte priming.
(C) Skewed lymphocyte differentiation could result in altered cytokine production, dysregulated humoral responses, and reduced cytotoxicity, manifesting in
defective or altered effector functions.
(D) Effects on memory B and T cell development and maintenance may occur, but it remains unclear whether these are direct effects on memory B and T cell
differentiation after the effector phase or reflect alterations in the early stages of the immune response.
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gens. Furthermore, interaction of helminths with epithelial cells
induces cytokines such as thymic stromal lymphopoietin
(TSLP), IL-25, and IL-33, which promote goblet cell hyperplasia
and mucus production (Artis and Grencis, 2008). Qualitative
changes in goblet cell mucins during intestinal helminth infec-
tions (Khan, 2008) may alter the intestinal microenvironment
and affect entry and/or survival of unrelated pathogens, while
accumulation of excessive mucus may impact vaccine uptake
at mucosal surfaces, decreasing vaccine efficacy (van Riet
et al., 2007). Thus, an altered intestinal mucosal environment
might affect initial entry of microbes and uptake of vaccines. In
support of this hypothesis, intestinal viral infection with poliovirus
or reovirus is impacted by the local microbial environment, since
bacterial polysaccharides enhance the infectivity and pathogen-
esis of these enteric viruses (Kuss et al., 2011). In this example,
the ‘‘bystander’’ microbe is nonpathogenic commensal bacteria
species (see below), but these data illustrate the point that
microbe-to-microbe interactions can influence the initial phases
of infection. Other mucosal surfaces are also subject to disrup-
tion of barrier integrity and altered infectivity by pathogens. For
example, epithelial cell damage in the genital mucosa during
HSV reactivation (Horbul et al., 2011), as well as downregulation
of mucosal immunemediators by HSV (Fakioglu et al., 2008), are
thought to increase the rate of infection with HIV. These effects462 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.might not be limited to chronic infections, since disruption of
epithelial integrity due to acute respiratory viral infections has
since long been thought to facilitate secondary bacterial infec-
tions (McCullers, 2006).
In addition to affecting pathogen entry via mucosal surfaces,
bystander chronic infections can also alter infectivity of target
cells and pathogen replication. Schistosoma (Bahgat et al.,
2010), Mtb (Zhang et al., 1995), and Plasmodium (Pisell et al.,
2002; Hawkes et al., 2010) have been reported to increase repli-
cation of unrelated pathogens in their target cells. Several mech-
anismsmight contribute to the increased cellular susceptibility to
infection during a bystander chronic infection. First, cellular infil-
tration induced by chronic inflammation may increase the accu-
mulation of target cells at the site of infection, thus promoting
host cell-pathogen interactions. For example, HSV reactivation
in mucosal tissues results in an influx of activated CD4 T cells,
which may facilitate HIV transmission (Zhu et al., 2009), and
a similar effect could be envisioned for other infections in the
genital or intestinal mucosa. Similarly,Plasmodium-induced infil-
tration of dysfunctional monocytes at sites of tuberculosis gran-
ulomas, which are clusters of immune cells, may contribute to
the inability to contain Mtb infection during Plasmodium/Mtb
coinfection (Hawkes et al., 2010). Second, persistent pathogens
may alter surface receptors expressed by bystander target
cells, thus facilitating infection with secondary pathogens. For
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modium infection may be facilitated by the increased expression
of the HIV coreceptors CXCR4 and CCR5 (Hoshino et al., 2004;
Moriuchi et al., 2002). These types of changes in initial pathogen
entry and/or cellular infection could lead to major changes in
early pathogen burden, substantially affecting downstream
innate and adaptive immunity.
In addition to altering mucosal barrier integrity and cellular
susceptibility to infection with unrelated pathogens, many
chronic infections evoke substantial changes in innate immune
cell development and function. Natural killer (NK) cell numbers
are reduced in tuberculosis patients during concomitant intes-
tinal helminth infection (Resende Co et al., 2007), as well as in
chronic HCV patients (Morishima et al., 2006). Impaired NK cell
development during chronic infection could play a role in the
defective early control of subsequent viral infections. Cytokine
production is another important mediator of innate immunity,
considerably affected by bystander chronic infections. IFN-a/b
responses by dendritic cells (DCs) and macrophages, crucial
for early antiviral control, are inhibited by IL-4 and IL-10 (Varano
et al., 2000; Sriram et al., 2007), amechanism potentially relevant
for the increased viral replication during coinfection with Th2-
inducing parasites. Furthermore, production of the Th1 cytokine
IL-1 by myeloid cells is suppressed by type I and type II IFN,
providing a potential mechanism for the regulation of Mtb immu-
nity by viral or other Th1-inducing coinfections (Mayer-Barber
et al., 2011).
Finally, hematopoiesis and the generation of myeloid lineage
cells can be dramatically impacted during chronic infections.
Sustained production of cytokines including type I and type II
IFN during chronic infections affects proliferation and differenti-
ation of hematopoietic stem cells (Essers et al., 2009; Baldridge
et al., 2010). While other examples of potential innate cross-
regulation exist that might impact responses during coinfection,
such as crosstalk between antiviral and antibacterial innate
sensing pathways (Abt et al., 2012; Ichinohe et al., 2011), clearly
more studies are needed to dissect how initial pathogen and
vaccine entry, uptake, and innate sensing are altered by by-
stander chronic infections.
Bystander Chronic Infections, APC Function, and Initial
Priming of B and T Lymphocytes
Intrinsic defects in innate immune cells caused by bystander
chronic infections may lead to altered APC function, reduced
antigen processing and presentation, and poor or altered pri-
ming of adaptive immune responses (Figure 1). The optimal initial
priming of T cell responses requires that DCs efficiently acquire
the antigen, home to the T cell zone of lymphoid tissues, process
and present antigen to T cells, and express the appropriate array
of costimulatory ligands to provide signal 2. Further, signal 3
from inflammatory mediators such as IFN-a/b, IL-12, IL-1, and
possibly IL-33 is critical for optimal T cell activation (Curtsinger
and Mescher, 2010; Bonilla et al., 2012).
This highly orchestrated set of events involved in initial priming
can be disrupted by bystander chronic infections. DC matura-
tion, costimulatory molecule expression, and cytokine produc-
tion are affected by chronic infections. For example, interaction
of DCs with helminth-associated antigens induces a partial
maturation of DCs (van Riet et al., 2007), a mechanism that
could be responsible for the subsequent reduced productionof cytokines and chemokines (Metenou et al., 2012), inefficient
antigen presentation, and induction of suboptimal T cell prolifer-
ation (Su et al., 2005). Disruption of the balance of costimulatory
versus coinhibitory signals can lead to tolerance, anergy, and/or
exhaustion rather than productive T cell priming (Macia´n et al.,
2004). Additionally, altered IFN-a/b and IL-12 production by
DCs during T cell priming decreases the efficiency of signal 3,
which is critical for optimal T cell activation. Therefore, immature
DCs providing suboptimal costimulation and cytokine signals
during T cell priming may account for the reduced adaptive
responses to unrelated antigens observed in several settings
of bystander chronic infection.
Antigen processing and presentation are also affected during
bystander chronic infections. For example, HSV impairs HIV
degradation in Langerhans cells, or skin-resident DCs, by
directly interacting with their degradation machinery (de Jong
et al., 2010). Similarly, Mtb infection impairs the degradative pro-
cessing and presentation of HIV by DCs (Reuter et al., 2010). On
the other hand, the process of transinfection, whereby DCs
deliver infectious virus to T cells without first being infected, is
enhanced during tuberculosis infection (Reuter et al., 2010).
Although a potentially fundamental mechanism for the increased
transmission of HIV among tuberculosis patients, it is unclear if
the enhanced ability of DCs to present virus in trans occurs in
other settings of chronic bystander infections.
An additional recently appreciated effect of chronic infections
is the dysregulation of lymphoid architecture. Both acute and
chronic infections induce a transient downregulation of CCL21
and CXCL13, the key chemokines involved in DC and lympho-
cyte homing to, and within, lymphoid tissues (Mueller et al.,
2007a). However, this period of altered chemokine production
and responsiveness might persist longer during chronic infec-
tions. Additional disruptions in lymphoid architecture, including
changes in follicular reticulocytes, could also lead to a dramati-
cally different priming environment during chronic coinfections
(Mueller et al., 2007b). While some evidence of altered lymphoid
tissue architecture exists for chronic HIV and HCV infections
(Dietrich et al., 1997; van Grevenynghe et al., 2008), the exact
consequences of such changes in the context of chronic coin-
fection or vaccination of chronically infected individuals remain
poorly defined.
Bystander Chronic Infections, Lymphocyte
Differentiation, and Development of Effector Functions
Development of the appropriately tailored effector B and T cell
responses is essential for control of many pathogens and is
the basis for rationale vaccine design. Bystander chronic infec-
tions have the potential to skew these effector lymphocyte
responses (Figure 1). For example, proliferative defects have
been observed in T cells from patients with chronic helminth
infections (Elias et al., 2001), or chronic HCV infection (Moorman
et al., 2011), and in animals with chronic Plasmodium infection
(Yin et al., 2012). At the time points examined, these proliferative
defects likely reflect long-term changes in APC populations
and/or altered populations of effector or memory T cells. CD8
T cell cytotoxicity, the hallmark of protective immunity against
intracellular pathogens, can also be dysregulated in the pres-
ence of bystander chronic infection, as shown by reduced
potential for degranulation and cytotoxicity, in the presence
of helminth infections or chronic HCV (Harcourt et al., 2005;Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 463
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low proliferative potential or altered function is intrinsic to the
T cells or reflects APC changes. However, in addition to altered
costimulatory and cytokine signals provided by APCs, as dis-
cussed above, the increased expression of inhibitory molecules
on bystander T cells from chronically infected patients (Babu
et al., 2009; Moorman et al., 2011) suggests that at least some
T cell intrinsic changes occur. Although the exact mechanisms
and consequences of T cell dysfunction during bystander
chronic infections remain to be more fully examined, blocking
inhibitory pathways has recently been proposed to enhance
immunity against unrelated antigens (Babu et al., 2009; Moor-
man et al., 2011).
Altered cytokine production during chronic infections is prob-
ably one of the main underlying immunological changes that
could impact increased susceptibility to other infections or
vaccine efficiency. Chronic helminth infections have been well
characterized for skewing toward Th2 and regulatory responses
(van Riet et al., 2007). This Th2 environment can dampen or
prevent protective Th1 responses and alter antibody isotypes
critical for protection or efficient vaccination against secondary
pathogens such as Plasmodium (Su et al., 2005; Metenou
et al., 2012), Mtb (Babu et al., 2009), HIV (Ayash-Rashkovsky
et al., 2002), and HCV (Farid et al., 2005). Although the role of
a global Th2 cytokine skewing in altering subsequent protective
Th1 immune responses has been widely documented, it remains
unclear whether this effect can be solely attributed to the
inhibition of IFN-g and other type 1-related pathways (e.g.,
T-bet-dependent pathways) by the Th2 cytokines IL-4 and/or
IL-13 or to altered APC function as well. Moreover, how such
skewing during bystander infections affects other CD4 T cell line-
ages, such as Th9, Th17, T regulatory (Treg) cells, and T follicular
helper (Tfh) cells, remains poorly understood.
Besides the prominent impact of global cytokine skewing,
there is also evidence for effects of sustained production of indi-
vidual cytokines due to bystander chronic infections. The
amount of IFN-g produced during Plasmodium/Mtb coinfection
correlates with the level of pathology observed (Page et al.,
2005; Leisewitz et al., 2008). It is also not clear whether different
innate inflammatory signals during priming impart important
qualitative properties on T (or perhaps B) cells tailored to the
specific infection. While there is some evidence that the program
of an IL-12 ‘‘conditioned’’ effector T cell might differ from an IFN-
a/b ‘‘conditioned’’ effector T cell (Xiao et al., 2009), it is not known
how such effects might manifest during chronic bystander infec-
tions and whether they would impact protective immunity.
Humoral immunity is also influenced by chronic bystander
infections. For example, skewing of antibody classes during
chronic helminth infections has been suggested to affect re-
sponses to secondary pathogens, such as Plasmodium (Druilhe
et al., 2005). Moreover, reduced antibody production upon
vaccination of chronically infected patients suggests that a
crucial common mechanism for the reduced vaccine efficacy
during bystander chronic infections involves altered B cell differ-
entiation and/or antibody production. Whether these effects are
B cell intrinsic; reflect altered development of Tfh cells, which
facilitate B cell development and antibody production and/or
function; or both remains to be investigated. However, altered
cytokine production by chronic infections can significantly affect464 Cell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc.the differentiation and survival of plasma cells that produce large
amounts of antibody (Elgueta et al., 2010), resulting in defective
antibody responses. Similarly, altered chemokine production
due to chronic bystander infections could affect B cell migration
and the formation of germinal centers where B cells differentiate
and proliferate. Abnormal B cell subpopulations, such as ex-
hausted or anergic B cells, are found in the periphery of HCV-
(Charles et al., 2011) and HIV-infected subjects (Moir and Fauci,
2009), and at least for HCV, there appear to be polyclonal
alterations affecting not only HCV-specific B cells. Further inves-
tigations of the effects of bystander chronic infections on the
development of germinal center B cells and plasma cell differen-
tiation, as well as the homing, survival, and function of these
critical components of the humoral response, will clarify the
mechanisms of altered antibody responses during chronic infec-
tions and potentially reveal opportunities for therapeutic inter-
ventions.
Bystander Chronic Infections and Memory Formation
and Maintenance
A critical issue for vaccinating individuals with ongoing chronic
infections is the development of effective, long-lasting immuno-
logical memory. Vaccination studies in chronically infected
individuals have demonstrated a detrimental effect on the devel-
opment of protective antibodies, suggesting possible defects in
humoral and/or T cell memory. During memory development,
B and T cells acquire or maintain several important properties,
including the ability to perform rapid effector function, longevity
via antigen-independent self-renewal or long life span (in the
case of plasma cells), wide anatomical distribution, and the
ability to mount robust recall responses (Figure 1). It is clear
that the development of high-quality B and T cell memory after
the effector phase of an immune response is a highly orches-
trated and complex process. However, it has been difficult to
determine whether the potential effects of bystander infections
reflect a direct impact on development of immunological
memory or indirect effects occurring during priming and effector
differentiation earlier in the response.
Recent studies in mice have demonstrated that inflammatory
cytokines can skew development of effector CD8 T cells toward
terminal differentiation and away from long-term memory devel-
opment (Joshi et al., 2007; Pham et al., 2009).While most studies
in animal models examine scenarios in which exposure to
antigen and inflammation is linked, these data raise interesting
questions regarding the potential impact of chronic inflammation
due to bystander infections (i.e., antigen-independent effects).
There is some evidence of bystander attrition of pre-existing
memory T cells during serial unrelated acute infections due to
IFN-a/b and/or IFN-g (Selin et al., 1999; McNally et al., 2001;
Dudani et al., 2008). However, similar attrition of preformed
memory CD8 T cells was not observed in other studies in which
memory T cell numbers were tracked following multiple subse-
quent distinct acute infections in mice (Vezys et al., 2009) or
during acute Epstein-Barr virus (EBV) infection in humans (Odu-
made et al., 2012). While the data on the numerical impact of
bystander chronic infection on memory maintenance remains
controversial, there is little information on how the differentiation
pattern of developing memory B and/or T cells is impacted by
bystander coinfections. Investigating the impact on memory
development is complicated by the need to distinguish effects
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events involved after priming that specifically impact memory
development. However, understanding the potential direct
effects of bystander chronic infections on memory cell quantity,
quality, and function will open new avenues for optimization of
vaccine strategies during bystander chronic infections and other
inflammatory conditions.
Persisting Infections Benefiting the Host
Much of the evidence on bystander chronic infections supports
a negative effect of chronic infections in regulating immune
responses to unrelated pathogens. This is the case for many
chronic viral, bacterial, or parasitic infections, as discussed
above. There are, however, also data suggesting a beneficial
effect of some persistent or latent infections in regulating host
immune responses. Although there are a large number of studies
supporting a negative effect of coinfection in host immunity, the
lack of evidence for positive effects does not necessarily imply
absence of potentially clinically unapparent beneficial combina-
tions of coinfection. For example, during infection with the
flavivirus GB virus C a clinical benefit of coinfection can be
observed. GB virus C can inhibit HIV replication, and HIV-in-
fected individuals who are coinfected with GB virus C have an
almost 4-fold reduced rate of mortality (Xiang et al., 2001).
Similarly, mice chronically infected with the protozoan parasite
Leishmania were protected against subsequent bacterial chal-
lenge, potentially due to the induced splenomegaly and expan-
sion of CD8 T cells (Polley et al., 2005).
Herpesviruses infect the majority of the human population and
establish latent, life-long infections with the risk for reactivation.
In a murine model of herpesviral infections, latent infection with
gammaherpesvirus (gHV) or murine cytomegolovirus (MCMV)
provided protection against subsequent bacterial infections
with Listeria monocytogenes or Yersinia pestis, due to an
increase in macrophage activation resulting from low-grade
IFN-g production (Barton et al., 2007). This protection provided
by gHV was also reported for subsequent adenovirus infection
(Nguyen et al., 2008). However, the benefit of gHV on subse-
quent infections was transient (Yager et al., 2009). These results
suggest an interesting potential coevolutionary benefit of
herpesviruses and their mammalian hosts. However, the stage
of herpesviral infection at which the secondary pathogen is
encountered could be a critical determinant of whether the
bystander infection is beneficial or detrimental. During latency,
gHV may provide protection against malaria. However, during
acute gHV infection, morbidity and mortality of malaria infection
were significantly enhanced (Haque et al., 2004). On the other
hand, although there may be some benefit of gHV infection
during latency, chronic low-grade inflammation from human
CMV infection has been associated with increased disease
progression and mortality during HIV (Emery et al., 1999), as
well as with accelerated decline in immune function or immuno-
senescence (Koch et al., 2007). Thus, animal models support
a transient beneficial effect of herpesviruses during latency;
however, the exact conditions under which a similar beneficial
effect may apply to humans remains to be defined.
It is not a major leap to expand these ideas to the effect of
commensal microbes in host immune responses. Indeed, it
could be argued that in the majority of immunocompetenthumans, herpesviruses are commensals or pathobionts, resi-
dent micro-organisms that can cause disease. Extending the
idea of interactions between different microbes and host
immunity, there are also examples of similar effects caused by
enteric bacterial flora. For example, commensal bacteria can
facilitate infection by enteric viruses (Kuss et al., 2011) but
have also been shown to modulate host responses to unrelated
pathogens and/or help tune the innate immune system for
optimal antiviral immune responses (Abt et al., 2012; Ichinohe
et al., 2011; Ganal et al., 2012). In some settings, basal activation
of the IFN system by commensal bacteria allowed subsequent
antiviral IFN-a/b signaling to occur at optimal efficiency (Abt
et al., 2012). Therefore, it appears that the mammalian immune
system has evolved to use sensing of environmental microbes
to maintain optimal immunological fitness and responsiveness.
This ability to sense persisting microbial signals might be bene-
ficial in some settings or detrimental in others. Understanding the
precise regulation of these positive and negative effects on
development and maintenance of immunity to other infections
and vaccines should provide opportunities to improve treatment
of chronic diseases in both the developed and the developing
world.
Concluding Remarks
This review has summarized epidemiological studies of coin-
fection and discussed evidence of possible underlying immuno-
logical pathways altered due to bystander chronic infections. A
fine balance of the inflammatory milieu may determine host
responses to subsequent immunological challenges. Disrupting
this balance either by decreasing basal inflammatory signals, by
altering symbiotic microorganisms, or by increasing and/or
altering inflammation with chronic bystander pathogenic infec-
tions can have detrimental effects on host immune responses
and survival. Defining the immunological mechanisms under-
lying the effects of coinfections and then devising strategies to
overcome these barriers to optimal immunological interventions
and vaccines in coinfected populations remains a major goal.
Our current understanding is that chronic bystander infections
affect immunity to unrelated pathogens and vaccines by target-
ing several different stages of the subsequent immune response.
Though the details of such mechanisms require further investi-
gation, it is obvious that different chronic pathogens may use
diverse pathways to alter host immune responses against unre-
lated infections, affecting early pathogenesis and innate immune
responses and/or later effector functions and adaptive immunity.
One common effect of coinfections appears to be that many
symptomatic chronic infections alter the initial stages of infection
with an unrelated pathogen, usually due to alterations of infec-
tivity or distribution of target cells. Unique mechanisms for
different chronic infections may also exist, such as the increased
ability of DCs for transinfection, induced by concomitant Mtb
infection. Nevertheless, a major common theme for the effects
of many coinfections is an altered host cytokine and/or inflam-
matory environment that can include increased or decreased
cytokine production or disruption of signaling and responses to
cytokines. These events, while they may differ in detail depend-
ing on the coinfection, have the potential to affect all stages of
immune responses (Figure 1). However, further studies in ex-
perimental models are needed to dissect the details of howCell Host & Microbe 12, October 18, 2012 ª2012 Elsevier Inc. 465
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Reviewindividual chronic infections affect subsequent innate and
adaptive immune responses. Given the large global population
harboring pathogenic chronic infections, it is likely that devel-
oping world vaccine efforts will be improved by a deeper mech-
anistic and clinical understanding of the effects of coinfection on
immunity to unrelated infections and vaccines.
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